3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2023 - 2030

3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2023 - 2030


3D Bioprinting Market Growth & Trends


The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.

In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.

The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.

North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.

3D Bioprinting Market Report Highlights

  • The medical segment accounted for the largest share of 37.6% in 2022 due to the increasing investment made in R&D
  • The magnetic levitation segment is anticipated to witness the highest CAGR of 13.7% over the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators
  • North America dominated the market in 2022 with a share of 30.9%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region
  • Some of the key players include Organovo; Envision TEC; Inventia Life Science PTY LTD; Poietis; Vivax Bio, LLC; Allevi; Cyfuse Biomedical K.K.; 3D Bioprinting Solutions; Cellink Global; Regemat 3D S.L.
Please note The report will be delivered in 3-8 business days upon order notification.


Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary technology & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 3D Bioprinting Market Outlook, 2018 - 2030
Chapter 3 Industry Outlook: Market Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Size and Growth Prospects
3.3 3D Bioprinting Market: Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advancement in the 3d bioprinting industry
3.3.1.2 Rising prevalence of chronic disease
3.3.1.3 Increasing use of 3d bioprinting in the pharmaceutical and cosmetology
3.3.2 Market restraint analysis
3.3.2.1 The high cost of 3D bioprinters
3.3.2.2 Lack of trained professionals
3.4 Industry Analysis - Porter’s
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Substitution Threat
3.4.4 New Entrants Threat
3.4.5 Competitive Rivalry
3.5 3D Bioprinting-SWOT Analysis, By PEST
3.5.1 Political landscape
3.5.2 Economic landscape
3.5.3 Social landscape
3.5.4 Technology landscape
3.6 Covid Impact Analysis
Chapter 4 3D Bioprinting Market: Technology Estimates & Trend Analysis
4.1 Global 3D Bioprinting Market: Technology Movement Analysis
4.2 Magnetic Levitation Technology
4.2.1 Global Magnetic Levitation technology market, 2018 - 2030 (USD Million)
4.3 Inkjet-based Technology
4.3.1 Global Inkjet-based technology market, 2018 - 2030 (USD Million)
4.4 Syringe-based Technology
4.4.1 Global Syringe-based technology market, 2018 - 2030 (USD Million)
4.5 Laser-based Technology
4.5.1 Global Laser-based technology market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Global Other technologies market, 2018 - 2030 (USD Million)
Chapter 6 3D Bioprinting Market: Application Estimates & Trend Analysis
6.1 Global 3D Bioprinting Market: Application Movement Analysis
6.2 Medical
6.2.1 Global medical market, 2018 - 2030 (USD Million)
6.2.2 Tissue and organ generation
6.2.2.1 Global tissue and organ generation market, 2018 - 2030 (USD Million)
6.2.3 Medical pills
6.2.3.1 Global Medical pills market, 2018 - 2030 (USD Million)
6.2.4 Prosthetics and implants
6.2.4.1 Global Prosthetics and implants market, 2018 - 2030 (USD Million)
6.2.5 Others
6.2.6.1 Global others application market, 2018 - 2030 (USD Million)
6.3 Dental
6.3.1 Global dental market, 2018 - 2030 (USD Million)
6.4 Biosensors
6.4.1 Global biosensors market, 2018 - 2030 (USD Million)
6.5 Consumer/Personal Product Testing
6.5.1 Global consumer/personal product testing market, 2018 - 2030 (USD Million)
6.6 Bioinks
6.6.1 Global bioinks market, 2018 - 2030 (USD Million)
6.7 Food and Animal Product
6.7.1 Global food and animal market, 2018 - 2030 (USD Million)
Chapter 7 3D Bioprinting Market: Regional Estimates & Trend Analysis, by Service, Technology, & Application
7.1 3D Bioprinting Market Share By Region, 2022 & 2030
7.2 North America
7.2.1 North America 3D Bioprinting market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.2.2.2 U.S. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.2.3.2 Canada 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe 3D Bioprinting market, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.2.2 U.K. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.3.2 Germany 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.4.2 France 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.5.2 Italy 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.6.2 Spain 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.7 Denmark
7.3.7.1 Denmark 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.7.2 Denmark 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Sweden 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.8.2 Sweden 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Norway 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.9.2 Norway 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific 3D Bioprinting market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.2.2 Japan 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.3.2 China 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.4.2 India 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.5 Thailand
7.4.5.1 Thailand 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.5.2 Thailand 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.6 Australia
7.4.6.1 Australia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.6.2 Australia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.7 South Korea
7.4.7.1 South Korea 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.7.2 South Korea 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America 3D Bioprinting market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.2.2 Brazil 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.3.2 Mexico 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.4.2 Argentina 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5.5 Columbia
7.5.5.1 Columbia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.5.2 Columbia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa 3D Bioprinting market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.2.2 South Africa 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.3.2 Saudi Arabia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.4.2 UAE 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Kuwait 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.5.2 Kuwait 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Envisiontec, Inc.
8.1.1.1 Company overview
8.1.1.2 Product benchmarking
8.1.1.3 Strategic initiatives
8.1.2 Organovo
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Inventia Life Science Pty Ltd
8.1.3.1 Company overview
8.1.3.2 Product benchmarking
8.1.4 POIETIS
8.1.4.1 Company overview
8.1.4.2 Product benchmarking
8.1.4.3 Strategic initiatives
8.1.5 VIVAX BIO, LLC
8.1.5.1 Company overview
8.1.5.2 Product benchmarking
8.1.5.3 Strategic initiatives
8.1.6 ALLEVI
8.1.6.1 Company overview
8.1.6.2 Product benchmarking
8.1.7 Cyfuse Biomedical K.K.
8.1.7.1 Company overview
8.1.7.2 Product benchmarking
8.1.7.3 Strategic initiatives
8.1.8 3D Bioprinting Solutions
8.1.8.1 Company overview
8.1.8.2 Product benchmarking
8.1.9 CELLINK GLOBAL
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 REGEMAT 3D S.L.
8.1.10.1 Company overview
8.1.10.2 Product benchmarking

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings